Central Pharmaceutical Joint Stock Company No3 reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was VND 100,910.86 million compared to VND 124,625.53 million a year ago. Net income was VND 31,614.35 million compared to VND 29,631.64 million a year ago. Basic earnings per share from continuing operations was VND 1,470.4 compared to VND 1,378.4 a year ago.
For the six months, revenue was VND 220,609.63 million compared to VND 251,328.04 million a year ago. Net income was VND 55,849.5 million compared to VND 51,788.83 million a year ago. Basic earnings per share from continuing operations was VND 2,597.6 compared to VND 2,408.8 a year ago.